首页|期刊导航|中华医学杂志（英文版）|Clinical development of chimeric antigen receptor-T cell therapy for hematological malignancies

Clinical development of chimeric antigen receptor-T cell therapy for hematological malignancies

Zhihuan Yang Ying Wang

中华医学杂志（英文版）2023，Vol.136Issue(19)：2285-2296,12.

中华医学杂志（英文版）2023，Vol.136Issue(19)：2285-2296,12.DOI:10.1097/CM9.0000000000002549

Clinical development of chimeric antigen receptor-T cell therapy for hematological malignancies

Zhihuan Yang ¹Ying Wang¹

作者信息

1. State Key Laboratory of Experimental Hematology,National Clinical Research Center for Blood Diseases,Haihe Laboratory of Cell Ecosystem,Institute of Hematology and Blood Diseases Hospital,Tianjin Key Laboratory of Cell Therapy for Blood Disease,Chinese Academy of Medical Sciences and Peking Union Medical College,Tianjin 300020,China
折叠

摘要

关键词

Cellular immunotherapy/Chimeric antigen receptor T cell/Hematological malignancy

Key words

Cellular immunotherapy/Chimeric antigen receptor T cell/Hematological malignancy

引用本文复制引用

Zhihuan Yang,Ying Wang..Clinical development of chimeric antigen receptor-T cell therapy for hematological malignancies[J].中华医学杂志（英文版）,2023,136(19):2285-2296,12.

基金项目

This review was supported by grants from Tianjin Municipal Science and Technology Commission Grant(No.20JCZDJC00120)and the Chinese Academy of Medical Sciences(CAMS)Innovation Fund for Medical Science(No.2020-I2M-C&T-A-019). （No.20JCZDJC00120）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINE

ISSN：0366-6999

访问量0

下载量0

段落导航